The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
Open accessAbstract
Diabetes mellitus comprises a group of carbohydrate metabolism disorders that share a common main feature of chronic hyperglycemia that results from defects of insulin secretion, insulin action, or both. Insulin is an important anabolic hormone, and its deficiency leads to various metabolic abnormalities in proteins, lipids, and carbohydrates. Atherosclerosis develops as a result of a multistep process ultimately leading to cardiovascular disease associated with high morbidity and mortality. Alteration of lipid metabolism is a risk factor and characteristic feature of atherosclerosis. Possible links between the two chronic disorders depending on altered metabolic pathways have been investigated in numerous studies. It was shown that both types of diabetes mellitus can actually induce atherosclerosis development or further accelerate its progression. Elevated glucose level, dyslipidemia, and other metabolic alterations that accompany the disease development are tightly involved in the pathogenesis of atherosclerosis at almost every step of the atherogenic process. Chronic inflammation is currently considered as one of the key factors in atherosclerosis development and is present starting from the earliest stages of the pathology initiation. It may also be regarded as one of the possible links between atherosclerosis and diabetes mellitus. However, the data available so far do not allow for developing effective anti-inflammatory therapeutic strategies that would stop atherosclerotic lesion progression or induce lesion reduction. In this review, we summarize the main aspects of diabetes mellitus that possibly affect the atherogenic process and its relationship with chronic inflammation. We also discuss the established pathophysiological features that link atherosclerosis and diabetes mellitus, such as oxidative stress, altered protein kinase signaling, and the role of certain miRNA and epigenetic modifications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Pathogenesis of atherosclerosis
Falk, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.068 · Cited by 1,447
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., Hristov, M., Köppel, T., Jahantigh, M. N., Lutgens, E., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000610 · Cited by 1,334
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Diabetes mellitus: The epidemic of the century
Kharroubi, A. T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.850 · Cited by 1,229
El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081188 · Cited by 1,115
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
NEWTON, A. C. (2003) · Biochemical Journal · doi:10.1042/bj20021626 · Cited by 798
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734
The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016) · Diabetes Care · doi:10.2337/dc15-1990 · Cited by 712
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., & Danesh, F. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-mr-134 · Cited by 596
Pathophysiology of Diabetic Dyslipidemia
Hirano, T. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17023 · Cited by 552 · cited 1×
“Diabetes-associated dyslipidemia received much attention during recent years and became the subject of numerous review papers [36,37].”
BackgroundBrasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
Katakami, N. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17014 · Cited by 472
Small Dense Low‐Density Lipoprotein as Biomarker for Atherosclerotic Diseases
Ivanova, E. A., Myasoedova, V. A., Melnichenko, A. A., Grechko, A. V., & Orekhov, A. N. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1273042 · Cited by 457
Self-citationNew insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Micro RNA ‐146 represses endothelial activation by inhibiting pro‐inflammatory pathways
Cheng, H. S., Sivachandran, N., Lau, A., Boudreau, E., Zhao, J. L., Baltimore, D., Delgado‐Olguin, P., Cybulsky, M. I., & Fish, J. E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202318 · Cited by 417
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386
Inflammation in atherosclerosis
Taleb, S. (2016) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2016.04.002 · Cited by 375
Wherrett, D. K., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Marks, J. B., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60895-7 · Cited by 371
Type 2 diabetes mellitus and cardiovascular disease: Genetic and epigenetic links
De Rosa, S., Arcidiacono, B., Chiefari, E., Brunetti, A., Indolfi, C., & Foti, D. P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00002 · Cited by 369
Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease
Maguire, E. M., Pearce, S. W. A., & Xiao, Q. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.08.002 · Cited by 366
Reactive oxygen species signaling in vascular smooth muscle cells
CLEMPUS, R., & GRIENDLING, K. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.033 · Cited by 358
Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db08-1607 · Cited by 348
Folco, E. J., Mawson, T. L., Vromman, A., Bernardes-Souza, B., Franck, G., Persson, O., Nakamura, M., Newton, G., Luscinskas, F. W., & Libby, P. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.118.311150 · Cited by 341
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
Everett, B. M., Donath, M. Y., Pradhan, A. D., Thuren, T., Pais, P., Nicolau, J. C., Glynn, R. J., Libby, P., & Ridker, P. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.002 · Cited by 329
Autoimmune type 1 diabetes: resolved and unresolved issues
Notkins, A. L., & Lernmark, Å. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14257 · Cited by 323
Keymeulen, B., Walter, M., Mathieu, C., Kaufman, L., Gorus, F., Hilbrands, R., Vandemeulebroucke, E., Van de Velde, U., Crenier, L., De Block, C., et al. (2010) · Diabetologia · doi:10.1007/s00125-009-1644-9 · Cited by 317
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Type 1 diabetes and coronary artery disease
Orchard, T. J., Costacou, T., Kretowski, A., & Nesto, R. W. (2006) · Diabetes Care · doi:10.2337/dc06-1161 · Cited by 305
NETosis is induced by high glucose and associated with type 2 diabetes
Menegazzo, L., Ciciliot, S., Poncina, N., Mazzucato, M., Persano, M., Bonora, B., Albiero, M., Vigili de Kreutzenberg, S., Avogaro, A., & Fadini, G. P. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0676-x · Cited by 278
Plaque Rupture in Humans and Mice
Schwartz, S. M., Galis, Z. S., Rosenfeld, M. E., & Falk, E. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000261709.34878.20 · Cited by 255
Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., et al. (2011) · Genome Research · doi:10.1101/gr.116095.110 · Cited by 223
Joshi, M. B., Lad, A., Bharath Prasad, A. S., Balakrishnan, A., Ramachandra, L., & Satyamoorthy, K. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.053 · Cited by 212
Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes
Roep, B. O., Atkinson, M., & von Herrath, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1502 · Cited by 212
Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180
MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States
Vasu, S., Kumano, K., Darden, C. M., Rahman, I., Lawrence, M. C., & Naziruddin, B. (2019) · Cells · doi:10.3390/cells8121533 · Cited by 179
Cnop, M., Vidal, J., Hull, R. L., Utzschneider, K. M., Carr, D. B., Schraw, T., Scherer, P. E., Boyko, E. J., Fujimoto, W. Y., & Kahn, S. E. (2007) · Diabetes Care · doi:10.2337/dc06-1834 · Cited by 174
The emerging challenge in diabetes: The “metabolic memory”
Ceriello, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.005 · Cited by 170
Tabit, C. E., Shenouda, S. M., Holbrook, M., Fetterman, J. L., Kiani, S., Frame, A. A., Kluge, M. A., Held, A., Dohadwala, M. M., Gokce, N., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.127514 · Cited by 170
Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?
Dahl‐Jørgensen, K., Larsen, J. R., & Hanssen, K. F. (2005) · Diabetologia · doi:10.1007/s00125-005-1832-1 · Cited by 168
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
Summerhill, V. I., Grechko, A. V., Yet, S.-F., Sobenin, I. A., & Orekhov, A. N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143561 · Cited by 166
Self-citationElbein, S. C., Hasstedt, S. J., Wegner, K., & Kahn, S. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5604 · Cited by 155
Epigenetic Changes in Diabetes and Cardiovascular Risk
Keating, S. T., Plutzky, J., & El-Osta, A. (2016) · Circulation Research · doi:10.1161/circresaha.116.306819 · Cited by 139
Chew, P., Yuen, D. Y. C., Stefanovic, N., Pete, J., Coughlan, M. T., Jandeleit-Dahm, K. A. M., Thomas, M. C., Rosenfeldt, F., Cooper, M. E., & de Haan, J. B. (2010) · Diabetes · doi:10.2337/db10-0195 · Cited by 128
Goldfine, A. B., Conlin, P. R., Halperin, F., Koška, J., Permana, P. A., Schwenke, D. C., Shoelson, S. E., & Reaven, P. D. (2013) · Diabetologia · doi:10.1007/s00125-012-2819-3 · Cited by 127
Das, S., Reddy, M. A., Senapati, P., Stapleton, K., Lanting, L. L., Wang, M., Samara, V. A., Ganguly, R., Zhang, L., Devaraj, S., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310663 · Cited by 122
Kim, W., Hudson, B. I., Moser, B., Guo, J., Rong, L., LU, Y., Qu, W., Lalla, E., Lerner, S. E., CHEN, Y., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1338.063 · Cited by 121
Inflammation, infection and atherosclerosis
Shah, P. K. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.01.004 · Cited by 115
Neutrophil-macrophage communication in inflammation and atherosclerosis
Nahrendorf, M., & Świrski, F. K. (2015) · Science · doi:10.1126/science.aac7801 · Cited by 114
Molecular mechanisms of plaque instability
Shah, P. K. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282efa326 · Cited by 111
Are reactive oxygen species still the basis for diabetic complications?
Marco, E. D., Jha, J. C., Sharma, A., Wilkinson‐Berka, J. L., Jandeleit-Dahm, K. A. M., & de Haan, J. B. (2015) · Clinical Science · doi:10.1042/cs20150093 · Cited by 90
Albers, J. J., Marcovina, S. M., Imperatore, G., Snively, B. M., Stafford, J. M., Fujimoto, W. Y., Mayer‐Davis, E. J., Petitti, D. B., Pihoker, C., Dolan, L. M., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2176 · Cited by 85
MicroRNA and Microvascular Complications of Diabetes
Barutta, F., Bellini, S., Mastrocola, R., Bruno, G., & Gruden, G. (2018) · International Journal of Endocrinology · doi:10.1155/2018/6890501 · Cited by 80
Molecular Mechanisms Linking Diabetes to the Accelerated Development of Atherosclerosis
Zeadin, M. G., Petlura, C., & Werstuck, G. H. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.06.001 · Cited by 77
Mice deficient in PKC β and apolipoprotein E display decreased atherosclerosis
Harja, E., Chang, J. S., Lü, Y., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-120345 · Cited by 75
miR-378a: a new emerging microRNA in metabolism
Machado, I. F., Teodoro, J. S., Palmeira, C. M., & Rolo, A. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03375-z · Cited by 73
Khan, M. I., Pichna, B. A., Shi, Y., Bowes, A. J., & Werstuck, G. H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2569 · Cited by 72
PKCβ Promotes Vascular Inflammation and Acceleration of Atherosclerosis in Diabetic ApoE Null Mice
Kong, L., Shen, X., Lin, L., Leitges, M., Rosario, R., Zou, Y. S., & Yan, S. F. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301113 · Cited by 69
Cheng, F., Torzewski, M., Degreif, A., Rossmann, H., Canisius, A., & Lackner, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072063 · Cited by 68
Τhe Antioxidant Function of HDL in Atherosclerosis
Xepapadaki, E., Zvintzou, E., Kalogeropoulou, C. P., Filou, S., & Kypreos, K. E. (2019) · Angiology · doi:10.1177/0003319719854609 · Cited by 62
Miname, M. H., & Santos, R. D. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.10.003 · Cited by 58
Catan, A., Turpin, C., Diotel, N., Patché, J., Guérin-Dubourg, A., Debussche, X., Bourdon, E., Ah-You, N., Moullec, N. L., Besnard, M., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.10.015 · Cited by 58
Energetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis
Martínez, M. S., García, A., Luzardo, E., Chávez-Castillo, M., Olivar, L. C., Salazar, J. J., Velasco, M., Quintero, J. J. R., & Bermúdez, V. (2017) · Vessel Plus · doi:10.20517/2574-1209.2017.34 · Cited by 53
Jun, J. Y., Ma, Z., & Segar, L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00034.2011 · Cited by 40
Hamasaki, S., Kobori, T., Yamazaki, Y., Kitaura, A., Niwa, A., Nishinaka, T., Nishibori, M., Mori, S., Nakao, S., & Takahashi, H. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-24325-y · Cited by 40
Chen, W., Li, X., Wang, J., Song, N., Zhu, A., & Jia, L. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12766 · Cited by 36
LDL electronegativity index: a potential novel index for predicting cardiovascular disease
Bobryshev, Ivanova, E. A., & Orekhov, A. N. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s74697 · Cited by 36
Self-citationDoes Elevated Glucose Promote Atherosclerosis? Pros and Cons
Bornfeldt, K. (2016) · Circulation Research · doi:10.1161/circresaha.116.308873 · Cited by 35
Osawa, S., Katakami, N., Kuroda, A., Takahara, M., Sakamoto, F., Kawamori, D., Matsuoka, T., Matsuhisa, M., & Shimomura, I. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.35592 · Cited by 35
Jun, J. Y., Ma, Z., Pyla, R., & Segar, L. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.031 · Cited by 33
Hagensen, M. K., Mortensen, M. B., Kjølby, M., Palmfeldt, J., Bentzon, J. F., & Gregersen, S. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.02.027 · Cited by 18
Pathobiology of familial hypercholesterolemic atherosclerosis.
Aliev, G. M., Castellani, R. J., Petersen, R. B., Burnstock, G., Perry, G. L., & Smith, M. A. (2004) · PubMed · Cited by 17
Cited by
Atherosclerosis: Recent developments
Björkegren, J. L. M., & Lusis, A. J. (2022) · Cell · doi:10.1016/j.cell.2022.04.004 · Cited by 1,249
Neutrophils in chronic inflammatory diseases
Herrero-Cervera, A., Soehnlein, O., & Kenne, E. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00832-3 · Cited by 695
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Recent Advances in Potential Health Benefits of Quercetin
Aghababaei, F., & Hadidi, M. (2023) · Pharmaceuticals · doi:10.3390/ph16071020 · Cited by 616
Malekmohammad, K., Bezsonov, E. E., & Rafieian-Kopaei, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.707529 · Cited by 346
Metadata
- Authors
- Poznyak, A., Grechko, A. V., Poggio, P., Myasoedova, V. A., Alfieri, V., & Orekhov, A. N.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-03-06
- Volume
- 21
- Issue
- 5
- Pages
- 1835
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3009960209
- Cited by
- 1,163
- References
- 84
- FWCI
- 80.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.